MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
B2190 H 89 2HCl3 CitationSummary: Potent PKA inhibitor
-
A8371 AZ 628Summary: Raf kinases,potent and ATP-competitive
-
A8374 AZD8330Target: MEKSummary: MEK 1/2 inhibitor
-
A8435 FurosemideTarget: Na /K /Cl- Symporters (NKCCs)|GABAA ReceptorsSummary: GABAA receptors antagonist
-
A8545 ZM336372Summary: C-Raf inhibitor, potent and selective
-
A8686 VX-745Target: p38Summary: P38α inhibitor,highly potent and selective
-
A8687 VX-702Summary: P38α MAPK inhibitor,highly selective and ATP-competitive
-
A8688 TAK-715Summary: p38 MAPK inhibitor
-
A8689 PD 169316Target: p38Summary: P38 MAPK inhibitor
-
B3261 RO4987655Summary: MEK inhibitor